Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Maione

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 1, 2015
Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancerFederica Maione, Enrico Giraudo
Angiogenesis|March 7, 2009
Semaphorins and tumor angiogenesisGuido Serini, Federica Maione, Enrico Giraudo, et al.
Cell Adhesion & Migration|July 21, 2016
Class 3 semaphorins in cardiovascular developmentDonatella Valdembri, Donatella Regano, Federica Maione, et al.
Journal of Leukocyte Biology|February 29, 2020
Chicken-or-egg question: Which came first, extracellular vesicles or autoimmune diseases?Federica Maione, Giuseppe Cappellano, Mattia Bellan, et al.
International Journal of Cancer|April 26, 2018
Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-"decoy" strategyCristina Basilico, Chiara Modica, Federica Maione, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 2017
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic ProgramDonatella Regano, Alessia Visintin, Fabiana Clapero, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistanceFederica Bessone, Chiara Dianzani, Monica Argenziano, et al.
Molecular & Cellular Proteomics : MCP|August 28, 2013
SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markersSara Zanivan, Federica Maione, Marco Y Hein, et al.
The Journal of Clinical Investigation|April 10, 2012
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in miceFederica Maione, Stefania Capano, Donatella Regano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 23, 2018
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse ModelsDaniela Dettori, Francesca Orso, Elisa Penna, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|February 1, 2015
Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancerFederica Maione, Enrico Giraudo
Angiogenesis|March 7, 2009
Semaphorins and tumor angiogenesisGuido Serini, Federica Maione, Enrico Giraudo, et al.
Cell Adhesion & Migration|July 21, 2016
Class 3 semaphorins in cardiovascular developmentDonatella Valdembri, Donatella Regano, Federica Maione, et al.
Journal of Leukocyte Biology|February 29, 2020
Chicken-or-egg question: Which came first, extracellular vesicles or autoimmune diseases?Federica Maione, Giuseppe Cappellano, Mattia Bellan, et al.
International Journal of Cancer|April 26, 2018
Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-"decoy" strategyCristina Basilico, Chiara Modica, Federica Maione, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 2017
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic ProgramDonatella Regano, Alessia Visintin, Fabiana Clapero, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistanceFederica Bessone, Chiara Dianzani, Monica Argenziano, et al.
Molecular & Cellular Proteomics : MCP|August 28, 2013
SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markersSara Zanivan, Federica Maione, Marco Y Hein, et al.
The Journal of Clinical Investigation|April 10, 2012
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in miceFederica Maione, Stefania Capano, Donatella Regano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 23, 2018
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse ModelsDaniela Dettori, Francesca Orso, Elisa Penna, et al.
Pageof 4